| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $923.67M | $569.55M | $468.04M | $232.26M | $103.67M |
| R&D | $794.31M | $476.64M | $332.34M | $169.45M | $78.41M |
| SG&A | $129.37M | $92.90M | $60.70M | $39.81M | $25.26M |
| Operating Income | -$923.67M | -$569.55M | -$468.04M | -$232.26M | -$103.67M |
| Interest Expense | – | – | $0.00 | $2.00K | $7.00K |
| Tax Expense | $0.00 | $0.00 | $0.00 | – | – |
| Net Income | -$766.63M | -$463.93M | -$402.27M | -$223.49M | -$100.08M |
| EPS (basic) | -5.6300 | -3.8000 | -4.1400 | -3.4400 | -1.9300 |
| EPS (diluted) | -5.6300 | -3.8000 | -4.1400 | -3.4400 | -1.9300 |
| Shares (diluted) | $136.09M | $122.00M | $97.16M | $64.88M | $51.92M |